Company Filing History:
Years Active: 2005
Title: Andrea Hasenohrl: Innovator in Pharmaceutical Chemistry
Introduction
Andrea Hasenohrl is a notable inventor based in Zagreb, Croatia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating bacterial infections. His work exemplifies the intersection of innovation and healthcare, showcasing the importance of research in combating diseases.
Latest Patents
Andrea Hasenohrl holds a patent for "9a-N-[N'-(phenylsulfonyl)carbamoyl] derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin A and of 5-O-desosaminyl-9-deoxo-9-dihydro-9a-aza-9a-homoerythronolide A." This patent, which includes 1 patent, details the preparation of these derivatives and their pharmaceutically acceptable addition salts with inorganic or organic acids. The compounds are designed for use in treating bacterial infections, highlighting their potential therapeutic applications.
Career Highlights
Andrea Hasenohrl is associated with Pliva d.d., a prominent pharmaceutical company known for its innovative drug development. His role at Pliva has allowed him to contribute to various projects that aim to enhance healthcare solutions. His expertise in pharmaceutical chemistry has been instrumental in advancing the company's research initiatives.
Collaborations
Throughout his career, Andrea Hasenohrl has collaborated with several talented individuals, including Nedjeljko Kujundzic and Mirjana Bukvic Krajacic. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Andrea Hasenohrl's contributions to pharmaceutical chemistry and his innovative patent demonstrate the vital role of inventors in the healthcare industry. His work continues to inspire future research and development in the fight against bacterial infections.